Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics

Journal of the National Cancer Institute

Volumn 103, Issue 15, 2011, Pages 1179-1189

  Yaghjyan, Lusine ^a   Colditz, Graham A ^a   Collins, Laura C ^b   Schnitt, Stuart J ^b   Rosner, Bernard ^c   Vachon, Celine ^d   Tamimi, Rulla M ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER RISK; CANCER SIZE; CONTROLLED STUDY; DENSITY; DIGITAL IMAGING; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL INFORMATION; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REGISTERED NURSE; TUMOR CLASSIFICATION; TUMOR VOLUME; UNITED STATES;

ADULT; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; LYMPH NODES; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM INVASIVENESS; NURSES; ODDS RATIO; POSTMENOPAUSE; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 79961238580     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr225     Document Type: Article

References (52)

1. Boyd NF, Rommens JM, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005;6(10):798-808. (Pubitemid 41430721)
2. Ginsburg OM, Martin LJ, Boyd NF. Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer. 2008;99(9):1369-1374.
3. Tamimi RM, Byrne C, Colditz GA, Hankinson SE. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2007;99(15):1178-1187. (Pubitemid 47233068)
4. Harvey JA, Bovbjerg VE. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology. 2004;230(1):29-41. (Pubitemid 37549780)
5. Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995;87(9):670-675.
6. Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995;87(21):1622-1629.
7. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6(3):R149-R156.
8. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492-2502. (Pubitemid 43854964)
9. Phipps AI, Li CI, Kerlikowske K, Barlow WE, Buist DS. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1643-1654.
10. Putti TC, El-Rehim DM, Rakha EA, et al. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod Pathol. 2005;18(1):26-35. (Pubitemid 40128091)
11. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869-10874. (Pubitemid 32878711)
12. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst. 2004;96(3):218-228. (Pubitemid 38263181)
13. Kwan M, Kushi L, Weltzien E, et al. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res. 2009;11(3):R31.
14. Rusiecki JA, Holford TR, Zahm SH, Zheng T. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detect Prev. 2005;29(5):419-426. (Pubitemid 41406136)
15. Yang XR, Sherman ME, Rimm DL, et al. Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev. 2007;16(3):439-443. (Pubitemid 46548646)
16. Colditz GA, Hankinson SE. The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer. 2005;5(5):388-396. (Pubitemid 40637830)
17. Tamimi RM, Baer HJ, Marotti J, et al. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res. 2008;10(4):R67.
18. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Vol X. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
19. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1159-1169.
20. Kerlikowske K, Cook AJ, Buist DS, et al. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol. 2010;28(24):3830-3837.
21. Ghosh K, Hartmann LC, Reynolds C, et al. Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol. 2010;28(13):2207-2212.
22. Byng JW, Boyd NF, Little L, et al. Symmetry of projection in the quantitative analysis of mammographic images. Eur J Cancer Prev. 1996;5(5):319-327. (Pubitemid 27006989)
23. Willett W, Stampfer MJ, Bain C, et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol. 1983;117(6):651-658. (Pubitemid 13100716)
24. Stampfer MJ, Willett WC, Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985;313(17):1044-1049. (Pubitemid 16243331)
25. Marshall RJ, Chisholm EM. Hypothesis testing in the polychotomous logistic model with an application to detecting gastrointestinal cancer. Stat Med. 1985;4(3):337-344. (Pubitemid 15019394)
26. Hinton CP, Roebuck EJ, Williams MR, et al. Mammographic parenchymal patterns: value as a predictor of hormone dependency and survival in breast cancer. AJR Am J Roentgenol. 1985;144(6):1103-1107. (Pubitemid 15000385)
27. Roubidoux MA, Bailey JE, Wray LA, Helvie MA. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. Radiology. 2004;230(1):42-48. (Pubitemid 37549781)
28. Aiello EJ, Buist DS, White E, Porter PL. Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2005;14(3):662-668. (Pubitemid 40489212)
29. Fasching PA, Heusinger K, Loehberg CR, et al. Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics. Eur J Radiol. 2006;60(3):398-404.
30. Ghosh K, Brandt KR, Sellers TA, et al. Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2008;17(4):872-879. (Pubitemid 351536418)
31. Yang WT, Dryden M, Broglio K, et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat. 2008;111(3):405-410.
32. Gierach GL, Lissowska J, Garcia-Closas M, et al. Relationship of mammographic density with breast cancer subtypes. in AACR 101st Annual Meeting; 2010. Washington, DC: American Association for Cancer Research.
33. Sala E, Solomon L, Warren R, et al. Size, node status and grade of breast tumours: association with mammographic parenchymal patterns. Eur Radiol. 2000;10(1):157-161. (Pubitemid 30141148)
34. Gill JK, Maskarinec G, Pagano I, Kolonel LN. The association of mammographic density with ductal carcinoma in situ of the breast: the multiethnic cohort. Breast Cancer Res. 2006;8(3):R30.
35. Ding J, Warren R, Girling A, Thompson D, Easton D. Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J. 2010;16(3):279-289.
36. Conroy SM, Pagano I, Kolonel KM, Maskarinec G. Mammographic density and breast cancer tumor characteristics in the Multiethnic Cohort Study. In AACR 101st Annual Meeting; 2010. Washington, DC: American Association for Cancer Research.
37. Ziv E, Tice J, Smith-Bindman R, et al. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2090-2095. (Pubitemid 40054303)
38. Reinier K, Vacek P, Geller B. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and postmenopausal women. Breast Cancer Res Treat. 2007;103(3):343-348. (Pubitemid 46944508)
39. D'Orsi CJ, Mendelson EB, Ikeda DM, et al. Breast Imaging Reporting and Data System: ACR BI-RADS - Breast Imaging Atlas. Reston, VA: American College of Radiology; 2003.
40. Ma H, Luo J, Press MF, et al. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(2):479-485.
41. Chen JH, Hsu FT, Shih HN, et al. Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI? Ann Oncol. 2009;20(8):1447-1449.
42. Lønning PE, Helle H, Duong NK, et al. Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status. J Steroid Biochem Mol Biol. 2009;117(1-3):31-41.
43. van Landeghem AA, Poortman J, Nabuurs M, Thijssen JH. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res. 1985;45(6):2900-2906. (Pubitemid 15232767)
44. Vermeulen A, Deslypere JP, Paridaens R, et al. Aromatase, 17 beta hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur J Cancer Clin Oncol. 1986;22(4):515-525. (Pubitemid 16113813)
45. Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92(13):1081-1087. (Pubitemid 30616482)
46. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225(1):165-175.
47. Leconte I, Feger C, Galant C, et al. Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. AJR Am J Roentgenol. 2003;180(6):1675-1679. (Pubitemid 36687107)
48. Porter GJR, Evans AJ, Cornford EJ, et al. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival. AJR Am J Roentgenol. 2007;188(3):676-683.
49. Ma L, Fishell E, Wright B, et al. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst. 1992;84(10):781-785.
50. Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology. 1992;184(3):613-617.
51. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546-1554. (Pubitemid 35277278)
52. Houssami N, Abraham LA, Miglioretti DL, et al. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA. 2011;305(8):790-799.